Home
NXGL

NXGL

NexGel Inc

as of 11-26-2025 3:13pm EST

$1.83

+$0.01

+0.32%

Stocks Health Care Medical/Dental Instruments Nasdaq

NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.

Chart Type:

Time Range:

Founded:	1997	Country:	United States
Employees:	N/A	City:	LANGHORNE
Market Cap:	15.6M	IPO Year:	2021
Target Price:	N/A	AVG Volume (30 days):	84.4K
Analyst Decision:	N/A	Number of Analysts:	N/A
Dividend Yield:	N/A	Dividend Payout Frequency:	N/A
EPS:	-0.38	EPS Growth:	N/A
52 Week Low/High:	$1.56 - $5.10	Next Earning Date:	11-11-2025
Revenue:	$11,666,000	Revenue Growth:	73.37%
Revenue Growth (this year):	46.6%	Revenue Growth (next year):	47.96%

AI-Powered NXGL Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold

Model Accuracy: 67.12%

67.12%

Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

View Full NXGL Forecast & Prediction with Hourly Data

Compare NXGL vs Leading Stocks

See how NXGL stacks up against similar companies in the market

Share on Social Networks:

Tools & Resources

Enhance your trading experience with our free tools

Free NXGL Stock Widget

Embed our interactive stock ticker widget on your website for real-time updates.

Free Tool

Stock Alerts on Telegram

Get instant notifications, market insights, and expert analysis delivered to your phone.

Live Updates

Disclaimer

The information presented on this page, "NXGL NexGel Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.